Use este identificador para citar ou linkar para este item:
http://www.repositorio.ufop.br/jspui/handle/123456789/14099
Título: | Nanoemulsion composed of 10-(4,5-dihydrothiazol-2-yl)thio)decan-1-ol), a synthetic analog of 3-alkylpiridine marine alkaloid : development, characterization, and antimalarial activity. |
Autor(es): | Silva, Marina Goulart da Cardoso, Jéssica Ferreira Perasoli, Fernanda Barçante Branquinho, Renata Tupinambá Mourão, Renata Silva Tavares, Harley da Silva Xocaira, Maria Luiza Costa Trench Guimarães, Daniel Silqueira Martins Viana, Gustavo Henrique Ribeiro Varotti, Fernando de Pilla Silva, Gisele Rodrigues da |
Palavras-chave: | Plasmodium falciparum Thiazole |
Data do documento: | 2020 |
Referência: | SILVA, M. G. da et al. Nanoemulsion composed of 10-(4,5-dihydrothiazol-2-yl)thio)decan-1-ol), a synthetic analog of 3-alkylpiridine marine alkaloid: development, characterization, and antimalarial activity. European Journal of Pharmaceutical Sciences, v. 151, p. 105382, 2020. Disponível em: <https://www.sciencedirect.com/science/article/abs/pii/S0928098720301718?via%3Dihub>. Acesso em: 10 jun. 2021. |
Resumo: | Malaria treatment is based on a reduced number of antimalarial drugs, and drug resistance has emerged, leading to the search for new antimalarial drugs incorporated into pharmaceutical formulations. In this study, 10-(4,5- dihydrothiazol-2-yl)thio)decan-1-ol) (thiazoline), a synthetic analog of 3-alkylpiridine marine alkaloid, and a potent antimalarial substance, was incorporated into O/W nanoemulsion. This formulation was prepared by a 23 factorial design. It was characterized by globule diameter, polydispersity index, zeta potential, encapsulation efficiency, in vitro thiazoline release at pH 2 and 6.86, and accelerated stability. In vitro and in vivo antimalarial activity was determined against P. falciparum and P. berghei, respectively. Thiazoline nanoemulsion showed 248.8 nm of globule diameter, 0.236 of polydispersity index, -38.5 mV of zeta potential, 96.92% encapsulation efficiency, and it was stable for 6 months. Thiazoline release profiles differed in acidic and neutral media, but in both cases, the nanoemulsion controlled and prolonged the thiazoline delivery. Thiazoline nanoemulsion exerted in vitro antimalarial activity against the parasite (IC50 = 1.32 µM), and it significantly reduced the in vivo parasitemia for 8 days without increasing the survival time of animals. Therefore, the thiazoline nanoemulsion represents a strategy to treat malaria combining an antimalarial candidate and a new nanocarrier. |
URI: | http://www.repositorio.ufop.br/jspui/handle/123456789/14099 |
Link para o artigo: | https://www.sciencedirect.com/science/article/abs/pii/S0928098720301718?via%3Dihub |
DOI: | https://doi.org/10.1016/j.ejps.2020.105382 v |
ISSN: | 0928-0987 |
Aparece nas coleções: | DEFAR - Artigos publicados em periódicos |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
ARTIGO_NanoemulsionComposedDihydrothiazol.pdf Restricted Access | 4,06 MB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.